Delivery Order SPE2DB25D3008-SPE2DB25FRCHM
Award Date 6/18/25
Potential Completion Date 6/20/25
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $35,031.63 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication used to treat autoimmune conditions...
- The Defense Logistics Agency awarded a $40,735.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 3, 2025. This non-set-aside award was issued on September 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $13,758.06 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order was issued on September 5, 2025, with a completion deadline of September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis...
- The Defense Logistics Agency awarded a $259,099.12 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations. ENBREL is a...
- The Defense Logistics Agency awarded a delivery order valued at $39,180.91 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of June 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor's Corporate Office division located in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis and other autoimmune conditions, and...
- The Defense Logistics Agency awarded a delivery order valued at $10,537.97 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant used primarily to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a delivery order valued at $11,160.01 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. ENBREL is a biologic immunosuppressant commonly used to treat rheumatoid arthritis, psoriasis, and other autoimmune...
- The Defense Logistics Agency awarded a $70,640.79 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion targeted for August 26, 2025. This competitively awarded, firm fixed-price contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $31,518.72 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with completion targeted for September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999.00 ceiling and extends through December 2026....